v3.26.1
Restatement of Previously Issued Consolidated Financial Statements - Equity Statement Restatement (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Dec. 27, 2025
Dec. 28, 2024
Error Corrections and Prior Period Adjustments Restatement [Line Items]            
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01  
Common stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01 $ 0.01 $ 0.01  
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred stock (in shares) 0 0 0 0 0 0
Preferred stock $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Beginning balance (in shares)     164,531,712      
Beginning balance     $ 767,202      
Net income 34,247 54,044 89,077 63,970    
Other comprehensive income (loss) $ (2,071) 38,915 $ (32,071) 56,398    
Ending balance (in shares) 164,979,816   164,979,816      
Ending balance $ 833,291 $ 685,061 $ 833,291 $ 685,061    
Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares) 164,895,622 164,274,617 164,531,712 163,842,248    
Beginning balance $ 1,649 $ 1,643 $ 1,645 $ 1,638    
Stock issued relating to Employee Stock Purchase Plan (in shares)     46,915 44,693    
Stock issued relating to Employee Stock Purchase Plan     $ 1 $ 1    
Shares issued for exercise/vesting of share-based compensation awards (in shares) 84,194   401,189 393,284    
Shares issued for exercise/vesting of share-based compensation awards $ 1   $ 4 $ 4    
Forfeiture of restricted stock awards (in shares)       (5,608)    
Forfeiture of restricted stock awards       $ 0    
Ending balance (in shares) 164,979,816 164,274,617 164,979,816 164,274,617    
Ending balance $ 1,650 $ 1,643 $ 1,650 $ 1,643    
Additional paid-in capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance 1,741,081 1,717,824 1,736,416 1,707,573    
Stock issued relating to Employee Stock Purchase Plan     428 523    
Share-based compensation expense 5,101 10,712 10,816 23,022    
Tax obligations for share-based compensation (688) (45) (2,166) (2,627)    
Ending balance 1,745,494 1,728,491 1,745,494 1,728,491    
Accumulated deficit            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (898,378) (1,083,444) (953,208) (1,093,370)    
Net income 34,247 54,044 89,077 63,970    
Ending balance (864,131) (1,029,400) (864,131) (1,029,400)    
Accumulated other comprehensive loss            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (47,651) (54,588) (17,651) (72,071)    
Other comprehensive income (loss) (2,071) 38,915 (32,071) 56,398    
Ending balance $ (49,722) $ (15,673) $ (49,722) $ (15,673)    
As Previously Reported            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred stock (in shares)   0   0    
Preferred stock   $ 0   $ 0    
Net income   47,564   53,070    
Other comprehensive income (loss)   41,343   62,012    
Ending balance   $ 743,395   $ 743,395    
As Previously Reported | Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   164,274,617   163,842,248    
Beginning balance   $ 1,643   $ 1,638    
Stock issued relating to Employee Stock Purchase Plan (in shares)       44,693    
Stock issued relating to Employee Stock Purchase Plan       $ 1    
Shares issued for exercise/vesting of share-based compensation awards (in shares)       393,284    
Shares issued for exercise/vesting of share-based compensation awards       $ 4    
Forfeiture of restricted stock awards (in shares)       (5,608)    
Forfeiture of restricted stock awards       $ 0    
Ending balance (in shares)   164,274,617   164,274,617    
Ending balance   $ 1,643   $ 1,643    
As Previously Reported | Additional paid-in capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance   1,709,580   1,699,851    
Stock issued relating to Employee Stock Purchase Plan       523    
Share-based compensation expense   11,290   23,078    
Tax obligations for share-based compensation   (45)   (2,627)    
Ending balance   1,720,825   1,720,825    
As Previously Reported | Accumulated deficit            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance   (997,077)   (1,002,583)    
Net income   47,564   53,070    
Ending balance   (949,513)   (949,513)    
As Previously Reported | Accumulated other comprehensive loss            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance   (70,903)   (91,572)    
Other comprehensive income (loss)   41,343   62,012    
Ending balance   $ (29,560)   $ (29,560)    
Restatement Impacts            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Preferred stock (in shares)   0   0    
Preferred stock   $ 0   $ 0    
Net income   6,480   10,900    
Other comprehensive income (loss)   (2,428)   (5,614)    
Ending balance   $ (58,334)   $ (58,334)    
Restatement Impacts | Common Stock            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance (in shares)   0   0    
Beginning balance   $ 0   $ 0    
Stock issued relating to Employee Stock Purchase Plan (in shares)       0    
Stock issued relating to Employee Stock Purchase Plan       $ 0    
Shares issued for exercise/vesting of share-based compensation awards (in shares)       0    
Shares issued for exercise/vesting of share-based compensation awards       $ 0    
Forfeiture of restricted stock awards (in shares)       0    
Forfeiture of restricted stock awards       $ 0    
Ending balance (in shares)   0   0    
Ending balance   $ 0   $ 0    
Restatement Impacts | Additional paid-in capital            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance   8,244   7,722    
Stock issued relating to Employee Stock Purchase Plan       0    
Share-based compensation expense   (578)   (56)    
Tax obligations for share-based compensation   0   0    
Ending balance   7,666   7,666    
Restatement Impacts | Accumulated deficit            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance   (86,367)   (90,787)    
Net income   6,480   10,900    
Ending balance   (79,887)   (79,887)    
Restatement Impacts | Accumulated other comprehensive loss            
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Beginning balance   16,315   19,501    
Other comprehensive income (loss)   (2,428)   (5,614)    
Ending balance   $ 13,887   $ 13,887